Discover
NVNO
enVVeno Medical Corporation
8.97
2 x 6.45
2 x 11.25
bid
ask
+
0.20
2.22%
2 @ 04:00 PM
8.97 +0.00 (0.00%)
| Ytd | -20.08% | |
| 1y | -72.57% |
8.64
day range
9.15
7.01
52 week range
35.70
| Open | 8.95 | Prev Close | 8.78 | Low | 8.64 | High | 9.15 | Mkt Cap | 6.24M |
| Vol | 7.85K | Avg Vol | 21.31K | EPS | -24.97 | P/E | N/A | Forward P/E | -2.45 |
| Beta | 1.22 | Short Ratio | 4.12 | Inst. Own | 29.76% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 10.64 | 200-d Avg | 10.93 | 1yr Est | 18.00 |
| Income Statement | |||
| Operating Expenses | 3.80M | ||
| Research and Development Expense | 2.08M | ||
| Selling, General and Administrative Expense | 1.72M | ||
| Operating Income | -3.80M | ||
| Net Income | -3.60M | ||
| Net Income Common Stock | -3.60M | ||
| Net Income Common Stock (USD) | -3.60M | ||
| Consolidated Income | -3.60M | ||
| Earnings per Basic Share | -5.37 | ||
| Earnings per Basic Share (USD) | -5.37 | ||
| Earnings per Diluted Share | -5.37 | ||
| Earning Before Interest & Taxes (EBIT) | -3.60M | ||
| Earning Before Interest & Taxes (USD) | -3.60M | ||
| Weighted Average Shares | 671.00K | ||
| Weighted Average Shares Diluted | 671.00K | ||
| Balance Sheet | |||
| Cash and Equivalents | 2.84M | ||
| Cash and Equivalents (USD) | 2.84M | ||
| Investments | 18.65M | ||
| Investments Current | 18.65M | ||
| Current Assets | 22.08M | ||
| Property, Plant & Equipment Net | 547.00K | ||
| Total Assets | 22.66M | ||
| Debt Current | 402.00K | ||
| Total Debt | 505.00K | ||
| Current Liabilities | 1.89M | ||
| Debt Non-Current | 103.00K | ||
| Total Liabilities | 1.99M | ||
| Accumulated Retained Earnings (Deficit) | -178.78M | ||
| Shareholders Equity | 20.67M | ||
| Shareholders Equity (USD) | 20.67M | ||
| Assets Non-Current | 578.00K | ||
| Total Debt (USD) | 505.00K | ||
| Liabilities Non-Current | 103.00K | ||
| Trade and Non-Trade Payables | 1.49M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 29.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 244.00K | ||
| Net Cash Flow from Investing | 3.67M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 3.67M | ||
| Net Cash Flow from Operations | -3.55M | ||
| Share Based Compensation | 397.00K | ||